RESULTS	After eight weeks of treatment , remission occurred in 51 percent of the patients in the group receiving 9 mg of budesonide ( 95 percent confidence interval , 39 to 63 percent ) , 43 percent of those receiving 15 mg ( 95 percent confidence interval , 31 to 55 percent ) , and 33 percent of those receiving 3 mg ( 95 percent confidence interval , 21 to 44 percent ) , as compared with 20 percent of those receiving placebo ( P < 0.001 , P = 0.009 , and P = 0.13 , respectively ) .\